Cite
HARVARD Citation
Uldrick, T. et al. (2017). A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma. Oncologist. pp. 505-e49. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Uldrick, T. et al. (2017). A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma. Oncologist. pp. 505-e49. [Online].